By reorganizing their management structure, diversifying their offering and presenting an altogether cleaner image, AstraZeneca Serbia has made tremendous progress since its beginnings in the Balkans in the late 1990s. Country Director Ksenija Purkovic discusses the future of the Anglo-Swedish outfit, and how best to navigate a market that is renowned for being tricky yet possessing boundless potential.
How did AstraZeneca operations come about in Serbia?
"The local requirements for national registration of a drug in Serbia, since Serbia is not part of the EU thus the centralized registration does not apply, is that one can only apply when the European Medical Agency approves the product."
